Literature DB >> 422225

Interference of propamidine with binding of the fifth component of complement to surface-fixed C3b, and with C5 activation.

W Vogt, G Schmidt, B Hinsch.   

Abstract

The effects of propamidine and their dose dependency, on utilization of the third and fifth complement components in immune haemolysis have been compared. While C3 utilization is not disturbed that of C5 is markedly inhibited by propamidine in concentrations as low as 0.5 mM. Both, binding of C5 to surface-fixed C3b and cleavage of C5 by convertases C42 and C3bBb, are also inhibited in the presence of propamidine. Since neither C3 cleavage by these enzymes nor even C5 cleavage by the cobra venom factor-supported convertase CFVBb is significantly reduced a general convertase-inhibiting effect of propamidine is ruled out. Rather the effect on utilization of C5 is the result of interference with binding of C5 is the result of interference with binding of C5 to C3b and hence impairment of its accessibility to the convertases. These findings thus further support the role of surface fixed C3b in C5 activation proposed earlier.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 422225      PMCID: PMC1457394     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  4 in total

1.  Interaction of the B-determinant of the third component of complement with amidino compounds.

Authors:  S S Asghar; R H Cormane
Journal:  Immunochemistry       Date:  1976-12

2.  Changes in antigenic properties of human C3 upon activation and conversion by trypsin.

Authors:  J L Molenaar; M A Müller; C P Engelfriet; K W Pondman
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

3.  Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.

Authors:  M Ballow; C G Cochrane
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

4.  Multiple effects of a diamidine (propamidine) on complement activation.

Authors:  W Vogt; B Hinsch; G Schmidt; I Von Zabern
Journal:  Immunology       Date:  1979-01       Impact factor: 7.397

  4 in total
  3 in total

1.  The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.

Authors:  R G DiScipio
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

2.  Effect on the human complement system of the major non-steroidal anti-inflammatory drugs: aspirin, indomethacin, phenylbutazone, oxyphenbutazone and sulindac.

Authors:  J O Minta; M B Urowitz; H A Smythe; D E Isenman
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

3.  Multiple effects of a diamidine (propamidine) on complement activation.

Authors:  W Vogt; B Hinsch; G Schmidt; I Von Zabern
Journal:  Immunology       Date:  1979-01       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.